Lung Cancer Screening Update: Management of Suspected Infectious and Inflammatory Findings on LDCT


The AJR Lecture Series brings presentations on the most important AJR articles to your desktop, available for viewing at home or office and on your schedule. This Lecture has an estimated time to complete the activity of 1 hour.


Target Audience:
The target audience for this activity is radiologists at all training levels with an interest in lung cancer screening.

Goals and Objectives:
After completing the material in this article, the learner should be able to:
  1. Explain the current management of suspected infectious and inflammatory lung abnormalities detected on LDCT based on the revised Lung-RADS lexicon; and
  2. Describe the prevalence of presumed acute infectious and inflammatory lung processes identified incidentally during lung cancer screening and their outcomes.


Disclosure of Commercial Interest:
  • B. Carter has nothing to disclose
  • D. Mendoza has nothing to disclose
  • C. Neumann has nothing to disclose


Member Price:
Free
NonMember Price:
$250.00

Accreditation Statement
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

Designation Statement
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.

Date of issuance: March 12, 2021
Date of expiration: March 11, 2024
Estimated time to complete the activity: 1 hour(s)